Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tums Assorted Fruit Antacid tablets
0101021C0BBAAAF
|
Tums | Calcium carbonate | Gastro-Intestinal System | 2 |
|
A1-Cal Max 1500mg chewable tablets
0905011D0BIABAK
|
A1-Cal | Calcium carbonate | Nutrition and Blood | 1 |
|
Calcium carbonate 300mg capsules
0101021C0AAANAN
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 1 |
|
A1-Cal 250mg effervescent tablets
0905011D0BIADAN
|
A1-Cal | Calcium carbonate | Nutrition and Blood | No data available |
|
AaCa Calcium carbonate 2.5g chewable tablets
0905011D0BLAAAG
|
AaCa | Calcium carbonate | Nutrition and Blood | No data available |
|
AaceCa 1250mg chewable tablets
0905011D0BJADAJ
|
AaceCa | Calcium carbonate | Nutrition and Blood | No data available |
|
AaceCa 1500mg chewable tablets
0905011D0BJAAAK
|
AaceCa | Calcium carbonate | Nutrition and Blood | No data available |
|
AaceCa 250mg dispersible tablets
0905011D0BJABAP
|
AaceCa | Calcium carbonate | Nutrition and Blood | No data available |
|
AaceCa 500mg effervescent tablets
0905011D0BJACAD
|
AaceCa | Calcium carbonate | Nutrition and Blood | No data available |
|
Boots Fruit Indigestion Relief 500mg tablets
0101021C0BLAAAF
|
Boots (Calcium carbonate) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Calcidrink 2.5g granules sachets
0905011D0BFAAAF
|
Calcidrink | Calcium carbonate | Nutrition and Blood | No data available |
|
Calcium 500 tablets
0905011D0BEAAAE
|
Calcium 500 | Calcium carbonate | Nutrition and Blood | No data available |
|
Calcium carbonate 1.25g/5ml oral suspension
0101021C0AACKCK
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Calcium carbonate 1.564g/5ml oral suspension
0101021C0AACNCN
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Calcium carbonate 100mg/5ml oral suspension
0101021C0AACTCT
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Calcium carbonate 125mg/5ml oral suspension
0101021C0AACUCU
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Calcium carbonate 1g/5ml oral suspension
0101021C0AACDCD
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Calcium carbonate 2.5g granules sachets
0905011D0AAAFAF
|
Calcium carbonate (Supplements) | Calcium carbonate | Nutrition and Blood | No data available |
|
Calcium carbonate 200mg/5ml oral suspension
0101021C0AACCCC
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Calcium carbonate 250mg tablets
0101021C0AABDBD
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Calcium carbonate 300mg/5ml oral suspension
0101021C0AACRCR
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Calcium carbonate 360mg/5ml oral suspension
0101021C0AACLCL
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Calcium carbonate 400mg/5ml oral suspension
0101021C0AACVCV
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Calcium carbonate 420mg tablets
0905022H0AAAAAA
|
Calc carb/glycine | Calcium carbonate | Nutrition and Blood | No data available |
|
Calcium carbonate 500mg capsules
0101021C0AAAPAP
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.